scholarly article | Q13442814 |
P356 | DOI | 10.1097/00007890-198336060-00005 |
P953 | full work available at URL | http://journals.lww.com/00007890-198336060-00005 |
P698 | PubMed publication ID | 6197792 |
P2093 | author name string | E. L. Reinherz | |
S. F. Schlossman | |||
C. B. Carpenter | |||
T. B. Strom | |||
G. J. Busch | |||
N. L. Tilney | |||
E. L. Milford | |||
R. L. Kirkman | |||
J. L. Araujo | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 620-626 | |
P577 | publication date | 1983-12-01 | |
P1433 | published in | Transplantation | Q15730500 |
P1476 | title | Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody | |
P478 | volume | 36 |
Q37390483 | A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis |
Q40770881 | Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells |
Q46622876 | Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell function |
Q49043970 | Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction. |
Q39818045 | Clinical applications of monoclonal antibodies |
Q42225955 | Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital |
Q24319426 | Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand |
Q33558294 | Current status of renal transplantation |
Q52129450 | Effect of immunosuppressants on OKT3 associated T cell activation: clinical implications. |
Q70386814 | Experience with cyclosporine and steroids in clinical renal transplantation |
Q36257761 | HEMCAM, an adhesion molecule expressed by c-kit+ hemopoietic progenitors |
Q33573621 | Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab |
Q37138277 | Immunological evaluation of rheumatoid arthritis patients treated with itolizumab |
Q70403714 | Immunosuppressive agents in renal transplantation |
Q40117551 | Immunosuppressive therapy for renal transplantation |
Q34528980 | In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates |
Q36350273 | In vivo effects of monoclonal antibodies to distinct epitopes of Qa-2 antigens |
Q67902658 | Monoclonal antibodies to CD6 preferentially stimulate T-cell clones with γ/δ rather than α/β aantigen receptors |
Q69920215 | Pediatric renal transplantation |
Q35304730 | Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients |
Q33810506 | Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts |
Q70376234 | Prophylactic use of a monoclonal antibody (33B3.1) directed against interleukin 2 receptor following human renal transplantation |
Q38730494 | Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases |
Q70014971 | Suppression of the local graft-vs.-host reaction in rats by treatment with a monoclonal antibody specific for the interleukin 2 receptor |
Q70235792 | The Human T-cell Circuit |
Q70354867 | The effect of skin allograft survival of a monoclonal antibody specific for a polymorphic CD3-like cell surface molecule in rhesus monkeys |
Q68832714 | The internal image-like anti-idiotypic response to a CD3-specific monoclonal antibody in primates is dependent on the T cell-binding properties of the injected antibody |
Q24336427 | The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins |
Q37333749 | The potential of biotechnology to improve the quality of life of patients with renal failure |
Q37084181 | The role of OKT3 in clinical transplantation |
Q36845422 | Use of monoclonal antibodies in human transplantation |
Search more.